Home/Filings/4/0001127602-19-017651
4//SEC Filing

Patton Cynthia M 4

Accession 0001127602-19-017651

CIK 0000318154other

Filed

May 6, 8:00 PM ET

Accepted

May 7, 7:02 PM ET

Size

10.2 KB

Accession

0001127602-19-017651

Insider Transaction Report

Form 4
Period: 2019-05-03
Transactions
  • Tax Payment

    Common Stock

    2019-05-03$176.50/sh174$30,71125,975 total
  • Award

    Common Stock

    2019-05-03+90226,877 total
  • Award

    Nqso (Right to Buy)

    2019-05-03+7,8767,876 total
    Exercise: $177.31From: 2021-05-03Exp: 2029-05-03Common Stock (7,876 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    262.308
Footnotes (5)
  • [F1]The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/3/2021, 5/3/2022 and 5/3/2023, respectively.
  • [F2]These shares include the following RSUs granted under the Company's equity plans: 348 RSUs which vest on 5/3/2020; 660 RSUs which vest in installments of 325 on 5/1/2020 and 335 on 5/1/2021; 901 RSUs which vest in installments of 297 on 4/27/2020, 297 on 4/27/2021 and 307 on 4/27/2022; and 902 RSUs which will vest in installments of 297 on 5/3/2021, 298 on 5/3/2022 and 307 on 5/3/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
  • [F3]These shares include 94 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
  • [F4]These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.
  • [F5]These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/3/2021, 5/3/2022 and 5/3/2023, respectively.

Issuer

AMGEN INC

CIK 0000318154

Entity typeother

Related Parties

1
  • filerCIK 0001560565

Filing Metadata

Form type
4
Filed
May 6, 8:00 PM ET
Accepted
May 7, 7:02 PM ET
Size
10.2 KB